Literature DB >> 2026895

Baseline sero-epidemiology of hepatitis B virus infection in children and teenagers in Italy. A survey before mass hepatitis B vaccination.

T Stroffolini1, M Chiaramonte, A Craxì, E Franco, M Rapicetta, R Trivello, D De Mattia, I Mura, A Giammanco, G Rigo.   

Abstract

During the period May 1987 to November 1989, the prevalence of hepatitis B virus (HBV) markers was determined by ELISA in serum samples of 7405 (55% male, 45% female) apparently healthy persons 3-19 years of age in Italy. Earlier studies of adults there had shown an intermediate degree of HBV endemicity (hepatitis B surface antigen carrier rate greater than 2%). Persons were selected by systematic cluster sampling in five different geographical areas of Italy. The overall prevalence of hepatitis B surface antigen (HBsAg) was 0.6%. The overall prevalence of at least one marker of HBV was 2.8%; it increased from 1.7% among children 3-5 years of age to 4.5% in teenagers 17-19 years of age (P less than 0.001). The prevalence of any HBV marker was higher in southern then in northern areas (3.5% vs. 1.8%, P less than 0.001). A significant association was found with sociodemographic features. Persons whose fathers had less than 6 years of schooling had a 2.3-fold risk (C.I. 95% = 1.5-3.4) while those belonging to a household of six or more under one roof had a 1.7-fold risk (C.I. 95% = 1.2-2.4) of previous exposure to HBV infection. These findings indicate that, today in Italy, exposure to HBV infection at a young age is very low and suggest a shift towards a low degree of endemicity following improvements in socio-economic conditions, decreased family size and increasing use of disposable syringes during recent years.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2026895     DOI: 10.1016/0163-4453(91)91723-b

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  7 in total

1.  Low prevalence of anti-HCV antibody among Italian children.

Authors:  L Romanò; A Azara; M Chiaramonte; D De Mattia; A Giammanco; M E Moschen; B Scarpa; T Stroffolini; A R Zanetti
Journal:  Infection       Date:  1994 Sep-Oct       Impact factor: 3.553

2.  Seroprevalence of pertussis in China: need to improve vaccination strategies.

Authors:  Yinghua Xu; Lichan Wang; Jin Xu; Xinjian Wang; Chen Wei; Peng Luo; Xiao Ma; Qiming Hou; Junzhi Wang
Journal:  Hum Vaccin Immunother       Date:  2013-09-09       Impact factor: 3.452

3.  Hepatitis B in children in Italy: incidence and risk factors: SEIEVA Collaborating Group. Sistema Epidemiologico Integrato dell'Epatite virale Acuta.

Authors:  R Corona; C Gandolfi; L Ferrigno; L Sagliocca; F Ciaralli; A Martelli; C Galanti; A Moiraghi; F Palumbo; F Novaco
Journal:  Eur J Epidemiol       Date:  1994-04       Impact factor: 8.082

4.  Low risk of mother to infant transmission of hepatitis B virus in Guipúzcoa (Basque country, northern Spain).

Authors:  E Pérez-Trallero; G Cilla; J Saenz; M Montes; P Idigoras
Journal:  Eur J Epidemiol       Date:  1992-11       Impact factor: 8.082

5.  Immune persistence after hepatitis B vaccination in infancy - Fact or fancy?

Authors:  Terence T Lao
Journal:  Hum Vaccin Immunother       Date:  2016-01-25       Impact factor: 3.452

6.  Incidence of hepatitis B virus infection among an Italian military population: evidence of low infection spread.

Authors:  R D'Amelio; T Stroffolini; R Nisini; P M Matricardi; M Rapicetta; E Spada; A Napoli; P Pasquini
Journal:  Eur J Epidemiol       Date:  1994-02       Impact factor: 8.082

7.  Age-specific prevalence of hepatitis B virus infection in young pregnant women, Hong Kong Special Administrative Region of China.

Authors:  Terence T Lao; Daljit S Sahota; Lai-Wa Law; Yvonne K Y Cheng; Tak-Yeung Leung
Journal:  Bull World Health Organ       Date:  2014-09-03       Impact factor: 9.408

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.